Outcomes of patients hospitalized for acute decompensated heart failure: Does nesiritide make a difference?

BMC Cardiovascular Disorders

Volumn 7, Issue , 2007, Pages

  Carroll, Richard J ^a   Mulla, Zuber D ^b,e   Hauck, Loran D ^c   Westbrook, Audrey ^d  

^a Adventist La Grange Memorial Hospital   (United States)

^b Paul L Foster School of Medicine   (United States)

^c Adventist Health System   (United States)

^d FLORIDA HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; MILRINONE; NESIRITIDE; BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; ADULT; ARTICLE; CAUCASIAN; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG USE; HISPANIC; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; NEGRO; NON PROFIT HOSPITAL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SOCIAL STATUS; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; ECONOMICS; FEMALE; HEART FAILURE; MALE; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK;

ADULT; AGED; AGED, 80 AND OVER; DRUG COSTS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38449113565     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-7-37     Document Type: Article

References (25)

1. American Heart Association Heart disease and stroke statistics - 2005 update http://www.americanheart.org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf
2. Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997, 45:968-74. 9256850
3. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997, 157:99-104. 10.1001/ archinte.157.1.99 8996046
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B: American College of Cardiology American Heart Association Task Force on Practice Guidelines American College of Chest Physicians International Society for Heart and Lung Transplantation Heart Rhythm Society ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-235. 10.1161/CIRCULATIONAHA.105.167586 16160202
5. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K: ESC Committe for Practice Guideline (CPG) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416. 10.1093/eurheartj/ehi044 15681577
6. Scios Inc Prescribing information, revised 4/29/05 http://www.natrecor.com/pdf/natrecor_pi.pdf
7. Michaels AD, Klein A, Madden JA, Chatterjee K: Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003, 107:2697-701. 10.1161/ 01.CIR.0000070547.88378.EA 12742984
8. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J: ADHERE Scientific Advisory Committee and Investigators ADHERE Study Group In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005, 46:57-64. 10.1016/ j.jacc.2005.03.051 15992636
9. Costanzo MR, Heywood JT, Emerman CL, Abraham WT, Yancy CW, Berkowitz RL, Cheng ML: Evaluation of in-hospital mortality in patients treated for acute heart failure within the first 24 hours with nesiritide vs. other vasoactive or inotropic agents [abstract]. Circulation 2003, 108(suppl IV):IV-695.
10. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson KD: Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials. JAMA 2005, 293:1900-5. 10.1001/jama.293.15.1900 15840865
11. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487-91. 10.1161/ 01.CIR.0000159340.93220.E4 15781736
12. Saul S: Heart clinic may end or curtail use of a drug. The New York Times http://www.nytimes.com/2005/05/04/health/04heart.html?ex= 1188532800&en=016cf22aa5f08596&ei=5070
13. Scios Inc Panel of cardiology experts recommendations toScios regarding Natrecor http://www.sciosinc.com/scios/pr_1118721302
14. Battleman DS, Callahan M, Thaler HT: Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: Link between quality of care and resource utilization. Arch Intern Med 2002, 162:682-8. 10.1001/ archinte.162.6.682 11911722
15. Hauck LD, Adler LM, Mulla ZD: Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia. Ann Epidemiol 2004, 14:669-75. 10.1016/j.annepidem.2004.01.003 15380798
16. 3M Health Information Systems: All patient refined diagnosis related groups (APR-DRGs) - methodology overview Document GRP-041, Version 20.0: 88 pages 2003
17. Cole SR: Analysis of complex survey data using SAS. Comput Methods Programs Biomed 2001, 64:65-9. 10.1016/S0169-2607(00)00088-2 11084234
18. Hosmer DW, Lemeshow S: Applied Logistic Regression New York: John Wiley and Sons 2 2000:313
19. Saul S: U.S. looking at marketing by Johnson & Johnson The New York Times http://www.nytimes.com/2005/07/21/business/21natrecor.html?ei= 5090&en=02f01378f6bfae24&ex=1279598400&partner= rssuserland&emc=rss&pagewanted=all
20. Carroll R, Mulla ZD, Hauck LD, Westbrook A: Nesiritide increases the odds of mortality among patients hospitalized for congestive heart failure [abstract]. Am J Epidemiol 2006, 163(Suppl):S1 10.1093/aje/kwj215
21. Carroll RJ, Mulla ZD, Hauck LD, Westbrook A: Mortality associated with nesiritide. Am Heart J 2007, 153:e43 10.1016/j.ahj.2007.03.039 17540185
22. Aaronson KD, Sackner-Bernstein J: Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA 2006, 296:1465-6. 10.1001/jama.296.12.1465 17003394
23. Fonarow GC, Corday E, ADHERE Scientific Advisory Committee: Overview of acutely decompensated congestive heart failure (ADHF): A report from the ADHERE registry. Heart Fail Rev 2004, 9:179-85. 10.1007/ s10741-005-6127-6 15809815
24. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure; a randomized controlled trial JAMA 2002, 287:1531-40. Erratum in JAMA 2002;288:577 10.1001/jama.287.12.1531 11911755
25. Topol EJ: Nesiritide - not verified. N Engl J Med 2005, 353:113-6. 10.1056/NEJMp058139 16014879